Activities of Paul RÜBIG related to 2008/0211(COD)
Plenary speeches (1)
Protection of animals used for scientific purposes (debate)
Amendments (3)
Amendment 33 #
Proposal for a directive
Recital 41
Recital 41
(41) To manage risks to human and animal health and the environment, Community legislation provides that substances and products can only be marketed after appropriate safety and efficacy data have been submitted. Some of those requirements can be fulfilled only by resorting to animal testing, hereinafter referred to as “regulatory testing”. It is necessarydesirable to introduce specific measures in order to increase the use of internationally accepted alternative approaches and to eliminate unnecessary duplication of regulatory testing. For that purpose Member States should recognise the validity of test data produced using internationally accepted test methods provided for in Community legislation.
Amendment 89 #
Proposal for a directive
Article 13 – paragraph 1
Article 13 – paragraph 1
1. Member States shall ensure that a procedure is not carried out if another scientifically satisfactory method or testing strategy of obtaining the result sought, not entailing the use of an animal, is recognised by Community legislation and internationally accepted. In the absence of such a method, a procedure may not be carried out if a scientifically satisfactory method or testing strategy for obtaining the result sought, including computer supported, in vitro and other methodologies, not entailing the use of an animal, is reasonably and practicablly available.
Amendment 176 #
Proposal for a directive
Article 38 – paragraph 4
Article 38 – paragraph 4
4. Without prejudice to paragraph 3, all projects involving only procedures classified as "up to mild"moderate" or less shall be exempted from the requirement for a retrospective assessment.